Biologists from University of Freiburg involved in collaborative project SynGlycTis which receives 1.9 million euros in funding
After its success in the first joint call by ERASynBio, the collaborative project Synthetic Glycobiology - new strategies to build and functionalise proto-cells and proto-tissues is now set to receive roughly 1.9 million euros in total funding. SynGlycTis is a collaboration of scientists from Denmark, Germany, the UK, France, and Austria.
Its members include Junior Professor Dr. Winfried Römer from the University of Freiburg and his team of researchers. The University of Freiburg team will now receive roughly 400,000 euros of the project’s overall funding from the German Federal Ministry of Education and Research for a period of 36 months. The scientists in the SynGlycTis project plan to produce so-called proto-cells to study their behaviour.
Proto-cells are artificial systems of vesicle-shaped membranes. They can be produced with the help of giant vesicles, which are also synthetic and imitate the membranes of natural cells. The researchers plan to use these synthetic proto-cells to gain a better understanding of processes in natural systems by replicating these. Proto-cells could also be used in the future as systems to transport active agents, for example. This means, medications could be administered more directly where needed and released over longer periods of time in a controlled way.
Proto-cells are much less complex than natural cells. One important element in natural cells that scientists have not yet been able to integrate in their synthetic counterparts is the so-called glycocalyx, which consists mainly of polysaccharides. It protects the cell membrane and also plays an important role in the interaction between cells, among other things. Lectins, which are proteins that can bind sugar, are also important for cellular interaction.
Some pathogens, like viruses and bacteria, use sugar-protein interaction to enter human cells. Sugar-protein interaction can also cause the formation of proto-organelles and proto-tissues. That is why Römer’s team is investigating not only the integration of components in giant vesicles, but also interaction within the proto-cell with the help of fluorescence and atomic force microscopes. The team’s goal is to build proto-organelles and proto-tissues.
The ERASynBio project provides funding for synthetic biology by structuring and coordinating research and necessary investments in several countries. Its goal is to establish a European research community in this field. ERASynBio is part of the seventh Framework Programme for research and technological development in the European Union.
Römer is a junior professor of synthetic biology of signalling processes at the cluster of excellence BIOSS Centre for Biological Signalling Studies and the Institute of Biology II of the University of Freiburg. He is also member of the Spemann Graduate School of Biology and Medicine, the International Research Training Group Soft Matter Science and the Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB) at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) in Freiburg.
More information about ERASynBio:
Junior Professor Dr. Winfried Römer
BIOSS Centre for Biological Signalling Studies
University of Freiburg
Phone: +49 761 - 203 - 67500
Rudolf-Werner Dreier | University of Freiburg
Scientists decipher key principle behind reaction of metalloenzymes
15.01.2018 | Rheinisch-Westfälische Technische Hochschule Aachen
New method to map miniature brain circuits
15.01.2018 | The Francis Crick Institute
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...
Scientists at Helmholtz Zentrum München have discovered a mechanism that amplifies the autoimmune reaction in an early stage of pancreatic islet autoimmunity prior to the progression to clinical type 1 diabetes. If the researchers blocked the corresponding molecules, the immune system was significantly less active. The study was conducted under the auspices of the German Center for Diabetes Research (DZD) and was published in the journal ‘Science Translational Medicine’.
Type 1 diabetes is the most common metabolic disease in childhood and adolescence. In this disease, the body's own immune system attacks and destroys the...
15.01.2018 | Event News
08.01.2018 | Event News
11.12.2017 | Event News
15.01.2018 | Physics and Astronomy
15.01.2018 | Life Sciences
15.01.2018 | Life Sciences